Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?

Andrea Sauer; Christian Putensen; Christian Bode

doi:10.1186/s13054-022-03909-1

Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?

Crit Care. 2022 Mar 22;26(1):74. doi: 10.1186/s13054-022-03909-1.

Authors

Andrea Sauer¹, Christian Putensen¹, Christian Bode²

Affiliations

¹ Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
² Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany. christian.bode@ukbonn.de.

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .

Publication types

Review

MeSH terms

Critical Care
Critical Illness* / therapy
Emergency Medicine*
Humans
Immunomodulation
Tetracyclines

Substances

Tetracyclines